Evidence map›Paper›PMID 30991053›Full record

ArticleExperimental eye research2019

Mutation in the mouse histone gene Hist2h3c1 leads to degeneration of the lens vesicle and severe microphthalmia.

Sharmilee Vetrivel, Natascia Tiso, Andrea Kügler, Martin Irmler, Marion Horsch, Johannes Beckers, Daniela Hladik, Florian Giesert, Valerie Gailus-Durner, Helmut Fuchs and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Experimental eye research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Forward genetic analysis using OCT screening identifiesProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Sharmilee VetrivelHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Developmental Genetics, D-85764 Neuherberg, Germany.
Natascia TisoDepartment of Biology, University of Padova, I-35131 Padova, Italy. Electronic address: natascia.tiso@unipd.it.
Andrea KüglerHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Developmental Genetics, D-85764 Neuherberg, Germany.
Martin IrmlerHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Experimental Genetics, D-85764 Neuherberg, Germany.
Marion HorschHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Experimental Genetics, D-85764 Neuherberg, Germany.
Johannes BeckersHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Experimental Genetics, D-85764 Neuherberg, Germany; Chair of Experimental Genetics, School of Life Science Weihenstephan, Technische Universität München, D-85354 Freising, Germany; German Center for Diabetes Research (DZD), D-85764 Neuherberg, Germany.
Daniela HladikHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Developmental Genetics, D-85764 Neuherberg, Germany.
Florian GiesertHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Developmental Genetics, D-85764 Neuherberg, Germany.
Valerie Gailus-DurnerHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Experimental Genetics, D-85764 Neuherberg, Germany.
Helmut FuchsHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Experimental Genetics, D-85764 Neuherberg, Germany.
Sibylle SabrautzkiHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Experimental Genetics, D-85764 Neuherberg, Germany; Helmholtz Center Munich, German Research Center for Environmental Health, Research Unit Comparative Medicine, D-85764 Neuherberg, Germany.
Martin Hrabě de AngelisHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Experimental Genetics, D-85764 Neuherberg, Germany; Chair of Experimental Genetics, School of Life Science Weihenstephan, Technische Universität München, D-85354 Freising, Germany; German Center for Diabetes Research (DZD), D-85764 Neuherberg, Germany.
Jochen GrawHelmholtz Center Munich, German Research Center for Environmental Health, Institute of Developmental Genetics, D-85764 Neuherberg, Germany. Electronic address: graw@helmholtz-muenchen.de.
Helmholtz Zentrum München · DEUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During an ENU (N-ethyl-N-nitrosourea) mutagenesis screen, we observed a dominant small-eye mutant mouse with viable homozygotes. A corresponding mutant line was established and referred to as Aey69 (abnormality of the eye #69). Comprehensive phenotyping of the homozygous Aey69 mutants in the German Mouse Clinic revealed only a subset of statistically significant alterations between wild types and homozygous mutants. The mutation causes microphthalmia without a lens but with retinal hyperproliferation. Linkage was demonstrated to mouse chromosome 3 between the markers D3Mit188 and D3Mit11. Sequencing revealed a 358 A-> C mutation (Ile120Leu) in the Hist2h3c1 gene and a 71 T-> C (Val24Ala) mutation in the Gja8 gene. Detailed analysis of eye development in the homozygous mutant mice documented a perturbed lens development starting from the lens vesicle stage including decreasing expression of crystallins as well as of lens-specific transcription factors like PITX3 and FOXE3. In contrast, we observed an early expression of retinal progenitor cells characterized by several markers including BRN3 (retinal ganglion cells) and OTX2 (cone photoreceptors). The changes in the retina at the early embryonic stages of E11.5-E15.5 happen in parallel with apoptotic processes in the lens at the respective stages. The excessive retinal hyperproliferation is characterized by an increased level of Ki67. The hyperproliferation, however, does not disrupt the differentiation and appearance of the principal retinal cell types at postnatal stages, even if the overgrowing retina covers finally the entire bulbus of the eye. Morpholino-mediated knock-down of the hist2h3ca1 gene in zebrafish leads to a specific perturbation of lens development. When injected into zebrafish zygotes, only the mutant mouse mRNA leads to severe malformations, ranging from cyclopia to severe microphthalmia. The wild-type Hist2h3c1 mRNA can rescue the morpholino-induced defects corroborating its specific function in lens development. Based upon these data, it is concluded that the ocular function of the Hist2h3c1 gene (encoding a canonical H3.2 variant) is conserved throughout evolution. Moreover, the data highlight also the importance of Hist2h3c1 in the coordinated formation of lens and retina during eye development.

Indexed as

Gene Knockdown TechniquesMutationAnimalsCrystallinsFemaleForkhead Transcription FactorsGene Expression Regulation, DevelopmentalHistonesHomeodomain ProteinsImmunohistochemistryIn Situ HybridizationKi-67 AntigenLens DiseasesMaleMiceMice, Inbred C3HCrystallinsForkhead Transcription FactorsFoxe3 protein, mouseHistoneshomeobox protein PITX3Homeodomain ProteinsKi-67 AntigenTranscription FactorsEye developmentHist2h3c1Histone geneLens degenerationMouseMutationRetina hyperproliferation

Identifiers

PMID30991053
PMCPMC6876282
OpenAlexW2937146189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.